Specialty Pharmacy Insights

[Video] How Providers Can Use the Oral Oncology Medication Mobile App

In the past two years alone, 25 new oncology medications have been approved by the FDA. That's the good news. The challenge is that staying up to date with all of the latest information about these drugs takes a lot of your time...time that could be ...

Read More

Introducing the Oncology Medication Mobile App

mHealth (mobile health) is becoming increasingly important for patient health. At Avella, we believe that having immediate access to information about medications and treatment regimens increases healthcare efficiencies, enhances the patient ...

Read More

How to Cope with a Cancer Diagnosis

Receiving a cancer diagnosis is an emotional experience for you, your family and your friends. Feelings of anger, frustration, and fear are normal. For most people, proactively addressing the diagnosis then exploring the options is the most ...

Read More

What is Infusion Therapy & What Diseases Does it Treat?

Sometimes when people become very ill with a complex disease, they cannot eat, let alone take medications orally. In addition, some medications cannot be given orally because the stomach acids will destroy them, and they will no longer be effective ...

Read More

6 Resources to Help Support the Fight Against Childhood Cancer

Every year, approximately 13,500 children are diagnosed with cancer in the U.S. More than 80% of children with cancer now survive 5 years or more, however cancer is still the second leading case of death in children (behind accidents). September is ...

Read More

[Complimentary Download] Oncology Medication Reference Chart for Providers

Do you treat oncology patients? Avella’s pharmacy support staff has years of experience helping cancer patients manage their condition and gain access to the latest, most effective oncology medications.  These include oral chemotherapy agents that ...

Read More

Janedu: New FDA-Approved Drug to Treat Chronic Iron Overload

Novartis announced this week that the US Food and Drug Administration has approved Jadenu™ (deferasirox) tablets.  Jadenu is a new oral tablet for the treatment of chronic iron overload. Chronic iron overload can occur due to blood transfusions in ...

Read More

5 Biggest Challenges for Stakeholders in the Oncology Value Chain

In 2014, Rebecca M. Shanahan was named Chief Executive Officer of Avella Specialty Pharmacy, after serving three years on the company’s board of directors.  The following interview was conducted  with Ms. Shanahan for the Institute for International ...

Read More

4 Ways to Show Your Support for Blood Cancer Awareness Month

Every September, The Leukemia & Lymphoma Society observes Blood Cancer Awareness Month.  LLS does this as a unique way to raise awareness about blood cancers and the work LLS is doing to advance research to find cures and provide access to ...

Read More

Mekinist and Tafinlar Approved for Advanced Melanoma

Avella is your pharmacy partner for oncology medications, Mekinist and Tafinlar, which are now approved for combination therapy. The United States Food and Drug Administration recently approved Mekinist, in combination with Tafinlar, to treat ...

Read More